A long-awaited generic version of Truvada, used for both HIV treatment and PrEP, went on the market Friday, October 2. But the wholesale cost of the new pill from Teva Pharmaceuticals – about $1,455 – ...

Bracing for generics to big-selling HIV prevention drug Truvada, Gilead Sciences is working to switch patients to its new option, Descovy. But the new med's additional benefits aren't worth the huge ...

When its U.S. patent cliff for HIV med Truvada was still on the horizon, Gilead Sciences won approval for follow-up med Descovy and launched an aggressive campaign to switch patients to the new drug.

A newly published cost-effectiveness study is questioning how much more payers should be willing to pay for a Gilead Sciences drug the Food and Drug Administration just approved for preventing HIV ...

A major health insurer has notified policy holders that it will no longer cover Gilead Sciences’ drug Descovy for pre-exposure prophylaxis, or PrEP, and will instead require them to switch to Truvada, ...

About 36,000 Americans develop HIV each year, according to the Centers for Disease Control and Prevention. And while there is a new FDA-approved medication (Apretude, approved in 2021) to treat those ...

The Food and Drug Administration on Monday approved the first drug shown to reduce the risk of HIV infection, a milestone in the 30-year battle against the virus that causes AIDS. The agency approved ...

Consumer Reports has no financial relationship with advertisers on this site. About 38,000 Americans develop HIV each year, according to the Centers for Disease Control and Prevention. Two ...

The United States is the only major economy on the planet where health care is a for-profit industry instead of a free public service; it's also the only place where the government allows health care ...

Most doctors agree Truvada is a boon in AIDS prevention; others express concern. July 16, 2012— -- The Food and Drug Adminstration today announced the approval of the first drug for use in people ...